Bioinformatics and Computational Biology Program, School of Systems Biology, George Mason University, Manassas, VA, 20110, USA.
Department of Ophthalmology, Howe Laboratory, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, 02114, USA.
Cladistics. 2020 Aug;36(4):358-373. doi: 10.1111/cla.12422. Epub 2020 Jul 14.
With the advent of high-resolution and cost-effective genomics and bioinformatics tools and methods contributing to a large database of both human (HAdV) and simian (SAdV) adenoviruses, a genomics-based re-evaluation of their taxonomy is warranted. Interest in these particular adenoviruses is growing in part due to the applications of both in gene transfer protocols, including gene therapy and vaccines, as well in oncolytic protocols. In particular, the re-evaluation of SAdVs as appropriate vectors in humans is important as zoonosis precludes the assumption that human immune system may be naïve to these vectors. Additionally, as important pathogens, adenoviruses are a model organism system for understanding viral pathogen emergence through zoonosis and anthroponosis, particularly among the primate species, along with recombination, host adaptation, and selection, as evidenced by one long-standing human respiratory pathogen HAdV-4 and a recent re-evaluation of another, HAdV-76. The latter reflects the insights on amphizoonosis, defined as infections in both directions among host species including "other than human", that are possible with the growing database of nonhuman adenovirus genomes. HAdV-76 is a recombinant that has been isolated from human, chimpanzee, and bonobo hosts. On-going and potential impacts of adenoviruses on public health and translational medicine drive this evaluation of 174 whole genome sequences from HAdVs and SAdVs archived in GenBank. The conclusion is that rather than separate HAdV and SAdV phylogenetic lineages, a single, intertwined tree is observed with all HAdVs and SAdVs forming mixed clades. Therefore, a single designation of "primate adenovirus" (PrAdV) superseding either HAdV and SAdV is proposed, or alternatively, keeping HAdV for human adenovirus but expanding the SAdV nomenclature officially to include host species identification as in ChAdV for chimpanzee adenovirus, GoAdV for gorilla adenovirus, BoAdV for bonobo adenovirus, and ad libitum.
随着高通量、低成本的基因组学和生物信息学工具和方法的出现,为人类(HAdV)和猿猴(SAdV)腺病毒的大型数据库做出了贡献,基于基因组学对它们的分类学进行重新评估是合理的。人们对这些特定腺病毒的兴趣日益增加,部分原因是它们在基因转移方案中的应用,包括基因治疗和疫苗,以及溶瘤方案。特别是,重新评估 SAdV 作为人类合适的载体非常重要,因为人畜共患病排除了人类免疫系统可能对这些载体一无所知的假设。此外,作为重要的病原体,腺病毒是一个了解病毒病原体通过人畜共患病和人兽共患病(特别是在灵长类物种中)出现的模型生物系统,包括重组、宿主适应性和选择,这一点从长期存在的人类呼吸道病原体 HAdV-4 和最近对另一种 HAdV-76 的重新评估中可以得到证明。后者反映了关于“双宿主感染”的认识,即在宿主物种之间(包括“非人类”)可能存在的非人类腺病毒基因组不断增加的数据库中,可能存在双向感染。HAdV-76 是一种从人类、黑猩猩和倭黑猩猩宿主中分离出来的重组病毒。腺病毒对公共卫生和转化医学的持续和潜在影响推动了对 GenBank 中存档的 174 种 HAdV 和 SAdV 全基因组序列的评估。结论是,观察到的不是单独的 HAdV 和 SAdV 进化枝,而是一个单一的、相互交织的树,所有 HAdV 和 SAdV 都形成混合进化枝。因此,建议使用单一的“灵长类动物腺病毒”(PrAdV)取代 HAdV 和 SAdV,或者保留 HAdV 用于人类腺病毒,但正式扩展 SAdV 命名法,包括宿主物种识别,如 ChAdV 用于黑猩猩腺病毒,GoAdV 用于大猩猩腺病毒,BoAdV 用于倭黑猩猩腺病毒,以及随意使用。